Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient
1 other identifier
interventional
8
1 country
1
Brief Summary
While delivery of an FMT-treatment to the cecum is visualized in a lower GI-endoscopy, it is uncertain whether delivery by enema distributes the FMT to the proximal segments of the colon. Positioning of the patient during the enema procedure may improve distribution to the proximal colon. Differences in distribution may explain the wide effect range and inferiority when enema is compared to delivery by lower GI endoscopy. Thus, in this study we will compare the distribution of FMT from delivery by lower GI endoscopy versus enema with and without positioning of the patient. We will use contrast fluid as a surrogate liquid for FMT to project the distribution on colon X-ray pictures. To our knowledge this is not done in any previous study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2021
CompletedFirst Submitted
Initial submission to the registry
November 3, 2021
CompletedFirst Posted
Study publicly available on registry
November 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2022
CompletedJune 6, 2022
October 1, 2021
7 months
November 3, 2021
June 1, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of cecum projection after CF delivery by lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.
Two radiologist determine the projection each colon X-ray picture by identifying segments where the gut mucosa is coated with contrast fluid and/or segments with contrast fluid in the lumen. The radiologist is blinded to which delivery method is used.
10 minutes after contrast fluid delivery
Secondary Outcomes (1)
Proportion of transverse colon projection after CF delivery by the lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.
10-20 minutes after contrast fluid delivery
Study Arms (1)
Contrast fluid by lower GI endoscopy and enema with and without positioning
EXPERIMENTALThere is a washout period of at least four weeks between the two interventions (delivery by lower GI endoscopy and enema)
Interventions
Each participant will receive one delivery of 440 ml contrast fluid by lower GI endoscopy to the cecum of the colon. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. An colon X-ray is obtained within 10 minutes after the contrast fluid is delivered. The participants is in a supine position fram delivery and until the colon x-ray is obtained.
Each participant will receive one delivery of 440 ml contrast fluid by enema. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. The enema procedure includes: 1. The participant lies on his/her left side in neutral position when the enema is delivered 2. X-ray of the colon is obtained with the participant lying on his/her back. 3. The participant is positioned back to his/her left sided position and tilted in a Trendelenburg position. The position is held for two minutes 4. The participant is turned to an abdominal position while the bed remains tilted in Trendelenburg position. 5. Participant turne to the right side. When positioned the bed is tilted the opposite way (anti-Trendelenburg.) The position is held for two minutes. 6. A second colon X-ray is obtained after the participants has rested for ten minutes in a supine neutral position
Eligibility Criteria
You may qualify if:
- Scheduled for colonoscopy at the medical department at UNN Harstad
- Able to complete the positioning procedure during the enema
You may not qualify if:
- Confirmed malignancy
- Inflammatory bowel disease
- Referral highly suspicious of cancer, inflammatory bowel disease or obstructive GI disease
- Contraindications for rectal catheter insertion (including known damage to pelvic floor, sphincter or the pudendal nerve)
- Use of anticoagulants. Use of acetylsalicylic acid is allowed
- Symptomatic cardiovascular or lung disease
- Kidney failure
- Known allergic reaction to any component in Liquid Polibar Plus
- Pregnant, lactating or planning pregnancy
- Asthma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of North Norway, Harstad
Harstad, Troms, 9406, Norway
Related Publications (1)
Skjevling LK, Hanssen HM, Valle PC, Goll R, Juul FE, Arlov O, Johnsen PH. Colonic distribution of FMT by different enema procedures compared to colonoscopy - proof of concept study using contrast fluid. BMC Gastroenterol. 2023 Oct 23;23(1):363. doi: 10.1186/s12876-023-02979-x.
PMID: 37872499DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter H Johnsen, MD PhD
University Hospital of North Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2021
First Posted
November 16, 2021
Study Start
October 25, 2021
Primary Completion
May 18, 2022
Study Completion
May 18, 2022
Last Updated
June 6, 2022
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Within 2021
Study protocol with statistical analysis plan will be uploaded to the ClinicalTrials.gov web site.